Seer

We are Seer, a life sciences company driven by the mission to unlock the complexities of the proteome to advance human health. We believe that a deeper, more comprehensive understanding of proteins is the next frontier in biology, holding the key to groundbreaking discoveries in health and disease. Our core focus is on empowering the scientific community by providing innovative tools and technologies that remove the traditional barriers associated with proteomics research. For too long, the study of proteins has been hampered by technological limitations, forcing researchers to choose between the scale of their studies and the depth of proteomic coverage. We are changing that paradigm.

At Seer, we are pioneering new ways to decode the secrets of the proteome. Our flagship Proteograph™ Product Suite, which includes proprietary engineered nanoparticles, consumables, an automation instrument, and advanced analysis software, offers an integrated solution for deep, unbiased, and large-scale proteomic analysis. This technology allows researchers to move beyond a pinhole view of the proteome to a panoramic understanding, revealing the breadth, depth, and dynamic nature of proteins and peptides in ways previously not possible. We are committed to making these powerful capabilities accessible to a broad range of researchers, from academic institutions to biopharmaceutical companies. Our aim is to foster an ecosystem where the vast potential of proteomics can be fully realized, accelerating the pace of scientific discovery and ultimately leading to transformative improvements in diagnosing and treating complex diseases. We are passionate about collaborating with scientists and researchers around the world to push the boundaries of what's possible in proteomics.